| For: | Bangoura G, Yang LY, Huang GW, Wang W. Expression of HIF-2α/EPAS1 in hepatocellular carcinoma. World J Gastroenterol 2004; 10(4): 525-530 [PMID: 14966910 DOI: 10.3748/wjg.v10.i4.525] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v10/i4/525.htm |
| Number | Citing Articles |
| 1 |
Inho Choi, Saipriya Lammata, Neha Merchant, Dongkyoo Park. Role of Transcription Factors in Gastrointestinal Malignancies. 2017; doi: 10.1007/978-981-10-6728-0_35
|
| 2 |
Oleksandr H. Minchenko, Dariia O. Tsymbal, Dmytro O. Minchenko, Michel Moenner, Olena V. Kovalevska, Nadia M. Lypova. Inhibition of kinase and endoribonuclease activity of ERN1/IRE1α affects expression of proliferationrelated genes in U87 glioma cells. Endoplasmic Reticulum Stress in Diseases 2015; 2(1) doi: 10.1515/ersc-2015-0002
|
| 3 |
Cynthia Ju, Sean P. Colgan, Holger K. Eltzschig. Hypoxia-inducible factors as molecular targets for liver diseases. Journal of Molecular Medicine 2016; 94(6) doi: 10.1007/s00109-016-1408-1
|
| 4 |
Bharath Nath, Gyongyi Szabo. Hypoxia and Hypoxia Inducible Factors: Diverse Roles in Liver Diseases. Hepatology 2012; 55(2) doi: 10.1002/hep.25497
|
| 5 |
J Shen. Effects of arsenic trioxide on apoptosis and proliferation of human lung cancer cells under hypoxia. Journal of Chinese Integrative Medicine 2008; 6(3) doi: 10.3736/jcim20080311
|
| 6 |
Tania Payo-Serafín, Carolina Méndez-Blanco, Jennifer Martínez-Geijo, Maria Kopsida, Beatriz San-Miguel, Juan José Ortiz-de-Urbina, Andrés García-Palomo, Femke Heindryckx, José L. Mauriz. Impeding hypoxia-driven tumor progression in hepatocellular carcinoma: clinical and pre-clinical analyses using 2D and 3D in vitro models. Biology Direct 2026; 21(1) doi: 10.1186/s13062-026-00796-2
|
| 7 |
XINTING PAN, QINGYUN ZHU, YUNBO SUN, LIANDI LI, YUNPENG ZHU, ZHIHUI ZHAO, JIANXIN ZUO, WEI FANG, KUN LI. PLGA/poloxamer nanoparticles loaded with EPAS1 siRNA for the treatment of pancreatic cancer in vitro and in vivo. International Journal of Molecular Medicine 2015; 35(4) doi: 10.3892/ijmm.2015.2096
|
| 8 |
Xiaotian Dong, Xiaoru Su, Jiong Yu, Jingqi Liu, Xiaowei Shi, Qiaoling Pan, Jinfeng Yang, Jiajia Chen, Lanjuan Li, Hongcui Cao. Homology modeling and molecular dynamics simulation of the HIF2α degradation-related HIF2α-VHL complex. Journal of Molecular Graphics and Modelling 2017; 71 doi: 10.1016/j.jmgm.2016.11.011
|
| 9 |
John Marentette, Cynthia Ju. Molecules, Systems and Signaling in Liver Injury. 2017; doi: 10.1007/978-3-319-58106-4_4
|
| 10 |
Changjun He, Xue‐Pu Sun, Haiquan Qiao, Xian Jiang, Dongdong Wang, Xiangguo Jin, Xuesong Dong, Jizhou Wang, Hongchi Jiang, Xueying Sun. Downregulating hypoxia‐inducible factor‐2α improves the efficacy of doxorubicin in the treatment of hepatocellular carcinoma. Cancer Science 2012; 103(3) doi: 10.1111/j.1349-7006.2011.02177.x
|
| 11 |
Jie Guo, Tomohiko Akahoshi, Yukie Mizuta, Masaharu Murata, Sayoko Narahara, Takahito Kawano, Yoshihiro Nagao, Shuo Zhang, Morimasa Tomikawa, Hirofumi Kawanaka, Makoto Hashizume. Histidine‐Rich Glycoprotein Alleviates Liver Ischemia/Reperfusion Injury in Mice With Nonalcoholic Steatohepatitis. Liver Transplantation 2021; 27(6) doi: 10.1002/lt.25960
|
| 12 |
Michele M. Hickey, M. Celeste Simon. . Current Topics in Developmental Biology 2006; 76 doi: 10.1016/S0070-2153(06)76007-0
|
| 13 |
Min Ju Kim, Hyeyoun Chang, Gihoon Nam, Youngji Ko, Sun Hwa Kim, Thomas M. Roberts, Ju Hee Ryu. RNAi-Based Approaches for Pancreatic Cancer Therapy. Pharmaceutics 2021; 13(10) doi: 10.3390/pharmaceutics13101638
|
| 14 |
Mengzhen Li, Faren Xie, Lu Wang, Guoxue Zhu, Lian-Wen Qi, Shujun Jiang. Celastrol: An Update on Its Hepatoprotective Properties and the Linked Molecular Mechanisms. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.857956
|
| 15 |
Fei Luo, Baofei Sun, Huiqiao Li, Yuan Xu, Yi Liu, Xinlu Liu, Lu Lu, Jun Li, Qingling Wang, Shaofeng Wei, Le Shi, Xiaolin Lu, Qizhan Liu, Aihua Zhang. A MALAT1/HIF-2α feedback loop contributes to arsenite carcinogenesis. Oncotarget 2016; 7(5) doi: 10.18632/oncotarget.6806
|
| 16 |
M.Christiane Brahimi-Horn, Jacques Pouysségur. . International Review of Cytology 2004; 242 doi: 10.1016/S0074-7696(04)42004-X
|
| 17 |
Joaquín Araos, Jonathan P. Sleeman, Boyan K. Garvalov. The role of hypoxic signalling in metastasis: towards translating knowledge of basic biology into novel anti-tumour strategies. Clinical & Experimental Metastasis 2018; 35(7) doi: 10.1007/s10585-018-9930-x
|
| 18 |
Vincent Wai-Hin Yuen, Carmen Chak-Lui Wong. Hypoxia-inducible factors and innate immunity in liver cancer. Journal of Clinical Investigation 2020; 130(10) doi: 10.1172/JCI137553
|
| 19 |
Ziyi Chen, Zhaomei Dong, Rong Zeng, Mengna Xu, Yuanyuan Zhang, Qu Dan, Guangming Wang. Association between single nucleotide polymorphisms in EPAS1 and PPARA genes and high altitude polycythemia in Chinese Tibetan population. Frontiers in Genetics 2025; 16 doi: 10.3389/fgene.2025.1519108
|
| 20 |
Aki Pui-Wah Tse, Karen Man-Fong Sze, Queenie Tsung-Kwan Shea, Elley Yung-Tuen Chiu, Felice Ho-Ching Tsang, David Kung-Chun Chiu, Misty Shuo Zhang, Derek Lee, Iris Ming-Jing Xu, Cerise Yuen-Ki Chan, Hui-Yu Koh, Chun-Ming Wong, Yong-Ping Zheng, Irene Oi-Lin Ng, Carmen Chak-Lui Wong. Hepatitis transactivator protein X promotes extracellular matrix modification through HIF/LOX pathway in liver cancer. Oncogenesis 2018; 7(5) doi: 10.1038/s41389-018-0052-8
|
| 21 |
|
| 22 |
Manqing Cao, Junrong Gao, Hongyuan Zhou, Jiafei Huang, Abin You, Zhigui Guo, Feng Fang, Wei Zhang, Tianqiang Song, Ti Zhang. HIF-2α regulates CDCP1 to promote PKCδ-mediated migration in hepatocellular carcinoma. Tumor Biology 2016; 37(2) doi: 10.1007/s13277-015-3527-7
|
| 23 |
Carolina Méndez-Blanco, Paula Fernández-Palanca, Flavia Fondevila, Javier González-Gallego, José L. Mauriz. Prognostic and clinicopathological significance of hypoxia-inducible factors 1α and 2α in hepatocellular carcinoma: a systematic review with meta-analysis. Therapeutic Advances in Medical Oncology 2021; 13 doi: 10.1177/1758835920987071
|
| 24 |
Alyssa Vito, Nader El-Sayes, Karen Mossman. Hypoxia-Driven Immune Escape in the Tumor Microenvironment. Cells 2020; 9(4) doi: 10.3390/cells9040992
|
| 25 |
Lian-Yue Yang, Feng Fang, Di-Peng Ou, Wei Wu, Zhi-Jun Zeng, Fan Wu. Solitary Large Hepatocellular Carcinoma. Annals of Surgery 2009; 249(1) doi: 10.1097/SLA.0b013e3181904988
|
| 26 |
Jung Hwa Lim, Dae-Ghon Kim, Dae-Yeul Yu, Hyun Mi Kang, Kyung Hee Noh, Dae-Soo Kim, Dongmin Park, Tae Kyung Chang, Dong-Soo Im, Cho-Rok Jung. Stabilization of E2-EPF UCP protein is implicated in hepatitis B virus-associated hepatocellular carcinoma progression. Cellular and Molecular Life Sciences 2019; 76(13) doi: 10.1007/s00018-019-03066-9
|
| 27 |
Enzhi Luo, Seongmin Lee, Neeraj manvi agarwal, Junjeong Choi. Targeting EPAS-1/HIF-2α Pathway to Address Endocrine Resistance in Luminal A Type Breast Cancer. Translational Oncology 2025; 57 doi: 10.1016/j.tranon.2025.102415
|
| 28 |
Hongjing Ma, Bin Liu, Shuoying Wang, Jing Liu. MicroRNA‐383 is a tumor suppressor in human lung cancer by targeting endothelial PAS domain‐containing protein 1. Cell Biochemistry and Function 2016; 34(8) doi: 10.1002/cbf.3237
|
| 29 |
Xiaowei Zheng, Yiwen Zhang, Yujia Liu, Luo Fang, Li Li, Jiao Sun, Zongfu Pan, Wenxiu Xin, Ping Huang. HIF‐2α activated lncRNA NEAT1 promotes hepatocellular carcinoma cell invasion and metastasis by affecting the epithelial‐mesenchymal transition. Journal of Cellular Biochemistry 2018; 119(4) doi: 10.1002/jcb.26481
|
| 30 |
Ainiwaer Talifu, Refuhati Saimaiti, Yusufu Maitinuer, Geyu Liu, Miernisha Abudureyimu, Xuelei Xin. Multiomics analysis profile acute liver injury module clusters to compare the therapeutic efficacy of bifendate and muaddil sapra. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-019-40356-5
|
| 31 |
Yang Liu, Yawei Liu, Xiaolu Yan, Yuan Xu, Fei Luo, Jing Ye, Han Yan, Xiaojun Yang, Xiaodan Huang, Jianping Zhang, Guozhong Ji. HIFs enhance the migratory and neoplastic capacities of hepatocellular carcinoma cells by promoting EMT. Tumor Biology 2014; 35(8) doi: 10.1007/s13277-014-2056-0
|
| 32 |
S.-L. Yang, L.-P. Liu, J.-X. Jiang, Z.-F. Xiong, Q.-J. He, C. Wu. The Correlation of Expression Levels of HIF-1 and HIF-2 in Hepatocellular Carcinoma with Capsular Invasion, Portal Vein Tumor Thrombi and Patients' Clinical Outcome. Japanese Journal of Clinical Oncology 2014; 44(2) doi: 10.1093/jjco/hyt194
|
| 33 |
Stefania Cannito, Umberto Dianzani, Maurizio Parola, Emanuele Albano, Salvatore Sutti. Inflammatory processes involved in NASH-related hepatocellular carcinoma. Bioscience Reports 2023; 43(1) doi: 10.1042/BSR20221271
|
| 34 |
Hye Jin Jung, Jong Hyeon Kim, Joong Sup Shim, Ho Jeong Kwon. A Novel Ca2+/Calmodulin Antagonist HBC Inhibits Angiogenesis and Down-regulates Hypoxia-inducible Factor. Journal of Biological Chemistry 2010; 285(33) doi: 10.1074/jbc.M110.135632
|
| 35 |
Chao Chen, Qianlei Yang, Dapeng Wang, Fei Luo, Xinlu Liu, Junchao Xue, Ping Yang, Hui Xu, Jiachun Lu, Aihua Zhang, Qizhan Liu. MicroRNA-191, regulated by HIF-2α, is involved in EMT and acquisition of a stem cell-like phenotype in arsenite-transformed human liver epithelial cells. Toxicology in Vitro 2018; 48 doi: 10.1016/j.tiv.2017.12.016
|
| 36 |
Carmen Chak-Lui Wong, Alan Ka-Lun Kai, Irene Oi-Lin Ng. The impact of hypoxia in hepatocellular carcinoma metastasis. Frontiers of Medicine 2014; 8(1) doi: 10.1007/s11684-013-0301-3
|